Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/B502d9a96ee1f6a38a72e416d01376dd9> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- B502d9a96ee1f6a38a72e416d01376dd9 NCIT_P378 "NCI" @default.
- B502d9a96ee1f6a38a72e416d01376dd9 type Axiom @default.
- B502d9a96ee1f6a38a72e416d01376dd9 annotatedProperty IAO_0000115 @default.
- B502d9a96ee1f6a38a72e416d01376dd9 annotatedSource NCIT_C37808 @default.
- B502d9a96ee1f6a38a72e416d01376dd9 annotatedTarget "A regimen consisting of gemcitabine and trastuzumab that may be used in the treatment of human epidermal growth factor receptor 2 (HER2)-positive recurrent or metastatic breast cancer." @default.